BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 24777584)

  • 1. Commissioning and first clinical application of mARC treatment.
    Dzierma Y; Nuesken FG; Kremp S; Palm J; Licht NP; Rübe C
    Strahlenther Onkol; 2014 Oct; 190(11):1046-52. PubMed ID: 24777584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel implementation of mARC treatment for non-dedicated planning systems using converted IMRT plans.
    Dzierma Y; Nuesken F; Licht N; Ruebe C
    Radiat Oncol; 2013 Aug; 8():193. PubMed ID: 23915350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two years experience with quality assurance protocol for patient related Rapid Arc treatment plan verification using a two dimensional ionization chamber array.
    Wagner D; Vorwerk H
    Radiat Oncol; 2011 Feb; 6():21. PubMed ID: 21342509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mARC vs. IMRT radiotherapy of the prostate with flat and flattening-filter-free beam energies.
    Dzierma Y; Bell K; Palm J; Nuesken F; Licht N; Rübe C
    Radiat Oncol; 2014 Nov; 9():250. PubMed ID: 25424536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mARC prostate treatment planning with Varian Eclipse for flat vs. FFF beams.
    Bell K; Dzierma Y; Palm J; Nuesken F; Licht N; Rübe C
    Phys Med; 2016 Mar; 32(3):474-8. PubMed ID: 27053450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monte Carlo modeling of HD120 multileaf collimator on Varian TrueBeam linear accelerator for verification of 6X and 6X FFF VMAT SABR treatment plans.
    Bergman AM; Gete E; Duzenli C; Teke T
    J Appl Clin Med Phys; 2014 May; 15(3):4686. PubMed ID: 24892341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of MLC leaf positioning accuracy for static and dynamic IMRT treatments using DAVID in vivo dosimetric system.
    Karagoz G; Zorlu F; Yeginer M; Yildiz D; Ozyigit G
    J Appl Clin Med Phys; 2016 Mar; 17(2):14-23. PubMed ID: 27074451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benchmarking the mARC performance - treatment time and dosimetric linearity.
    Dzierma Y; Nuesken F; Licht N; Rübe C
    Z Med Phys; 2016 Dec; 26(4):339-348. PubMed ID: 26947444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of intensity-modulated radiotherapy and forward-planning dynamic arc therapy techniques for prostate cancer.
    Metwaly M; Awaad AM; El-Sayed EM; Sallam ASM
    J Appl Clin Med Phys; 2008 Oct; 9(4):37-56. PubMed ID: 19020481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosimetric verification for intensity-modulated arc therapy plans by use of 2D diode array, radiochromic film and radiosensitive polymer gel.
    Hayashi N; Malmin RL; Watanabe Y
    J Radiat Res; 2014 May; 55(3):541-52. PubMed ID: 24449714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical experience with planning, quality assurance, and delivery of burst-mode modulated arc therapy.
    Kainz K; Prah D; Ahunbay E; Li XA
    J Appl Clin Med Phys; 2016 Sep; 17(5):47-59. PubMed ID: 27685123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Planning for mARC treatments with the Eclipse treatment planning system.
    Sarkar V; Huang L; Rassiah-Szegedi P; Zhao H; Huang J; Szegedi M; Salter BJ
    J Appl Clin Med Phys; 2015 Mar; 16(2):5351. PubMed ID: 26103202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetric study of 2D ion chamber array matrix for the modern radiotherapy treatment verification.
    Saminathan S; Manickam R; Chandraraj V; Supe SS
    J Appl Clin Med Phys; 2010 Apr; 11(2):3076. PubMed ID: 20592695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical implementation of intensity-modulated arc therapy.
    Yu CX; Li XA; Ma L; Chen D; Naqvi S; Shepard D; Sarfaraz M; Holmes TW; Suntharalingam M; Mansfield CM
    Int J Radiat Oncol Biol Phys; 2002 Jun; 53(2):453-63. PubMed ID: 12023150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IMRT and RapidArc commissioning of a TrueBeam linear accelerator using TG-119 protocol cases.
    Wen N; Zhao B; Kim J; Chin-Snyder K; Bellon M; Glide-Hurst C; Barton K; Chen D; Chetty IJ
    J Appl Clin Med Phys; 2014 Sep; 15(5):4843. PubMed ID: 25207569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IMRT delivery performance with a varian multileaf collimator.
    Losasso T
    Int J Radiat Oncol Biol Phys; 2008; 71(1 Suppl):S85-8. PubMed ID: 18406945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of pulsed IMRT and VMAT for re-irradiation treatments: dosimetric and delivery feasibilities.
    Lin MH; Price RA; Li J; Kang S; Li J; Ma CM
    Phys Med Biol; 2013 Nov; 58(22):8179-96. PubMed ID: 24200917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of machines on plan quality: volumetric modulated arc therapy and intensity modulated radiation therapy.
    Clemente S; Cozzolino M; Oliviero C; Fiorentino A; Chiumento C; Fusco V
    Clin Transl Oncol; 2014 Feb; 16(2):141-6. PubMed ID: 23645162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mARC preoperative rectal cancer treatments vs. 3D conformal radiotherapy. A dose distribution comparative study.
    Bermúdez Luna R; de Torres Olombrada MV
    PLoS One; 2019; 14(8):e0221262. PubMed ID: 31419263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-specific 3D pretreatment and potential 3D online dose verification of Monte Carlo-calculated IMRT prostate treatment plans.
    Boggula R; Jahnke L; Wertz H; Lohr F; Wenz F
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1168-75. PubMed ID: 21093168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.